These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26477692)

  • 21. Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials.
    Mori M; Takei S; Imagawa T; Imanaka H; Nerome Y; Kurosawa R; Kawano Y; Yokota S; Sugiyama N; Yuasa H; Fletcher T; Wajdula JS
    Mod Rheumatol; 2011 Dec; 21(6):572-8. PubMed ID: 21479889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of etanercept on leptin and ghrelin secretion in children with juvenile idiopathic arthritis.
    Maciejewska-Paszek I; Grochowska-Niedworok E; Siwiec A; Gruenpeter A; Dul L; Irzyniec T
    J Int Med Res; 2017 Apr; 45(2):525-532. PubMed ID: 28415953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic analysis of plasma to reveal the impact of short-term etanercept therapy in pediatric patients with enthesitis-related arthritis: a case report.
    Chen YC; Wang PW; Pan TL; Bazylak G; Shen JJ
    Comb Chem High Throughput Screen; 2010 Jul; 13(6):469-81. PubMed ID: 20402637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis.
    Taddio A; Cattalini M; Simonini G; Cimaz R
    Expert Rev Clin Immunol; 2016 Jun; 12(6):641-9. PubMed ID: 26809126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etanercept in methotrexate-resistant JIA-related uveitis.
    Saeed MU; Raza SH; Goyal S; Cleary G; Newman WD; Chandna A
    Semin Ophthalmol; 2014 Jan; 29(1):1-3. PubMed ID: 24175644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JNK Pathway-Associated Phosphatase as a Serum Marker for Disease Activity and Treatment Outcome of Juvenile Idiopathic Arthritis.
    Zhu S; Lv H; Luo Y; Huang Q; Shen J
    Tohoku J Exp Med; 2021 Jan; 253(1):19-28. PubMed ID: 33441511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of etanercept on refractory systemic-onset juvenile idiopathic arthritis.
    Hu X; Yuan F; Zhang J; Yin L; Li BR; Jin YL
    World J Pediatr; 2016 Feb; 12(1):96-102. PubMed ID: 25754755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis Patients Treated with Biologics.
    Barthel D; Ganser G; Kuester RM; Onken N; Minden K; Girschick HJ; Hospach A; Horneff G
    J Rheumatol; 2015 Nov; 42(11):2160-5. PubMed ID: 26373564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis.
    Smith JA; Thompson DJ; Whitcup SM; Suhler E; Clarke G; Smith S; Robinson M; Kim J; Barron KS
    Arthritis Rheum; 2005 Feb; 53(1):18-23. PubMed ID: 15696578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan.
    Mori M; Takei S; Imagawa T; Imanaka H; Nerome Y; Higuchi R; Kawano Y; Yokota S; Sugiyama N; Yuasa H; Fletcher T; Wajdula JS
    Mod Rheumatol; 2012 Sep; 22(5):720-6. PubMed ID: 22212889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
    Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
    Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment in a child with enthesitis-related arthritis involving the sternoclavicular joint: a case report.
    Huang PY; Chang LS; Guo MM; Kuo HC
    BMC Pediatr; 2019 Oct; 19(1):373. PubMed ID: 31647009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optic neuritis associated with etanercept therapy for juvenile arthritis.
    Tauber T; Turetz J; Barash J; Avni I; Morad Y
    J AAPOS; 2006 Feb; 10(1):26-9. PubMed ID: 16527676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
    Prince FH; Twilt M; ten Cate R; van Rossum MA; Armbrust W; Hoppenreijs EP; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; van Suijlekom-Smit LW
    Ann Rheum Dis; 2009 May; 68(5):635-41. PubMed ID: 18413443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TNF and LT binding capacities in the plasma of arthritis patients: effect of etanercept treatment in juvenile idiopathic arthritis.
    Gudbrandsdottir S; Larsen R; Sørensen LK; Nielsen S; Hansen MB; Svenson M; Bendtzen K; Müller K
    Clin Exp Rheumatol; 2004; 22(1):118-24. PubMed ID: 15005015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis.
    Prince FH; Geerdink LM; Borsboom GJ; Twilt M; van Rossum MA; Hoppenreijs EP; Cate RT; Koopman-Keemink Y; van Santen-Hoeufft M; Raat H; van Suijlekom-Smit LW
    Ann Rheum Dis; 2010 Jan; 69(1):138-42. PubMed ID: 19581280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour necrosis factor alpha promoter polymorphisms and etanercept therapy in juvenile idiopathic arthritis.
    Schmeling H; Horneff G
    Rheumatol Int; 2007 Feb; 27(4):383-6. PubMed ID: 16951943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone status over 1 yr of etanercept treatment in juvenile idiopathic arthritis.
    Simonini G; Giani T; Stagi S; de Martino M; Falcini F
    Rheumatology (Oxford); 2005 Jun; 44(6):777-80. PubMed ID: 15741191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients.
    Southwood TR; Foster HE; Davidson JE; Hyrich KL; Cotter CB; Wedderburn LR; Hull RG; Venning HE; Rahman JK; Cummins CL;
    Rheumatology (Oxford); 2011 Jan; 50(1):189-95. PubMed ID: 21047801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Periodontal conditions in juvenile idiopatic arthritis.
    Maspero C; Giannini L; Galbiati G; Prevedello C; Farronato G
    Minerva Stomatol; 2017 Apr; 66(2):43-50. PubMed ID: 27588378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.